Last updated on May 2018

A Randomized, Double-Blind, Vehicle-Controlled Study to Evaluate the Efficacy and Safety of Topical Administration of Study Drug for 12 Weeks in the Treatment of Moderate-to-Severe Acne Vulgaris


Brief description of study

A Randomized, Double-Blind, Vehicle-Controlled Study to Evaluate the Efficacy and Safety of Topical Administration of Study Drug for 12 Weeks in the Treatment of Moderate-to-Severe Acne Vulgaris

Detailed Study Description

To evaluate the efficacy in the treatment of acne compared to vehicle of topical FMX101 4% administered daily for 12 weeks. Subjects will apply (or have it applied) the assigned study drug topically once daily for 12 weeks as directed. Subjects will be advised to apply the study drug at approximately the same time each day, preferably about 1 hour before bedtime.

Clinical Study Identifier: TX153896

Contact Investigators or Research Sites near you

Start Over
Sorry. There are no research Sites conducting this study in the radius provided. ( View all Sites )